VibroSense Dynamics AB (publ.) markets and develops medical devices that support diagnosis of peripheral sensory neuropathy. The company was founded in 2005 with headquarters in Malmö, Sweden. Our customers are primarily healthcare, hospitals, diabetes clinics, occupational healthcareand research scientists.
Follow Vibrosense on Instagram:
Listed on Spotlight Stock Market since May 2015, VibroSense Dynamics AB has a portfolio that includes a CE-marked medical device for diagnosing impaired sensitivity on human hands and feet. The device is used clinically at all major centers for Occupational and Environmental Medicine in Sweden and Norway. Impaired sensitivity is a characteristic finding in feet of people with diabetes, a population estimated at over 425 million worldwide.